348 related articles for article (PubMed ID: 31395342)
1. MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m
He H; Wu W; Sun Z; Chai L
Biochem Biophys Res Commun; 2019 Oct; 517(4):581-587. PubMed ID: 31395342
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LINC00240 promotes gastric cancer progression via modulating miR-338-5p/METTL3 axis.
Wang G; Zhang Z; Xia C
Bioengineered; 2021 Dec; 12(2):9678-9691. PubMed ID: 34842045
[TBL] [Abstract][Full Text] [Related]
3. Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer.
Zhang F; Yan Y; Cao X; Zhang J; Li Y; Guo C
Aging (Albany NY); 2021 Apr; 13(8):12224-12238. PubMed ID: 33882457
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-1269b inhibits gastric cancer development through regulating methyltransferase-like 3 (METTL3).
Kang J; Huang X; Dong W; Zhu X; Li M; Cui N
Bioengineered; 2021 Dec; 12(1):1150-1160. PubMed ID: 33818282
[TBL] [Abstract][Full Text] [Related]
5. METTL3-mediated m
Ji G; Wang X; Xi H
Int J Immunopathol Pharmacol; 2023; 37():3946320231204694. PubMed ID: 37823387
[TBL] [Abstract][Full Text] [Related]
6. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer.
Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY
J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471
[TBL] [Abstract][Full Text] [Related]
7. Circ-PRMT5 promotes gastric cancer progression by sponging miR-145 and miR-1304 to upregulate MYC.
Du W; Li D; Guo X; Li P; Li X; Tong S; Tong J; Kuang L; Liang D
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4120-4130. PubMed ID: 31701767
[No Abstract] [Full Text] [Related]
8. METTL3-mediated m
Wang Q; Chen C; Ding Q; Zhao Y; Wang Z; Chen J; Jiang Z; Zhang Y; Xu G; Zhang J; Zhou J; Sun B; Zou X; Wang S
Gut; 2020 Jul; 69(7):1193-1205. PubMed ID: 31582403
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor ATF2 promotes gastric cancer progression by activating the METTL3/cyclin D1 pathway.
Meng H; Li J; Sun H; Lin Y; Xu H; Zhang N
Drug Dev Res; 2023 Sep; 84(6):1325-1334. PubMed ID: 37421203
[TBL] [Abstract][Full Text] [Related]
11. METTL3-mediated m6A modification of KIF3C-mRNA promotes prostate cancer progression and is negatively regulated by miR-320d.
Ma H; Zhang F; Zhong Q; Hou J
Aging (Albany NY); 2021 Sep; 13(18):22332-22344. PubMed ID: 34537760
[TBL] [Abstract][Full Text] [Related]
12. miR-24-3p Regulates Progression of Gastric Mucosal Lesions and Suppresses Proliferation and Invasiveness of N87 Via Peroxiredoxin 6.
Li Q; Wang N; Wei H; Li C; Wu J; Yang G
Dig Dis Sci; 2016 Dec; 61(12):3486-3497. PubMed ID: 27743162
[TBL] [Abstract][Full Text] [Related]
13. HBXIP promotes gastric cancer
Yang Z; Jiang X; Li D; Jiang X
Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
[TBL] [Abstract][Full Text] [Related]
14. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis.
Huang T; Kang W; Zhang B; Wu F; Dong Y; Tong JH; Yang W; Zhou Y; Zhang L; Cheng AS; Yu J; To KF
Mol Cancer; 2016 Jan; 15():9. PubMed ID: 26801246
[TBL] [Abstract][Full Text] [Related]
15. MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9.
Liu Q; Jiang J; Fu Y; Liu T; Yu Y; Zhang X
Biomed Pharmacother; 2018 Sep; 105():420-427. PubMed ID: 29879625
[TBL] [Abstract][Full Text] [Related]
16. Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase.
Tokumaru Y; Tajirika T; Sugito N; Kuranaga Y; Shinohara H; Tsujino T; Matsuhashi N; Futamura M; Akao Y; Yoshida K
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959742
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of miR-802 suppresses gastric cancer oncogenicity via targeting RAB23 expression.
Zhang XY; Mu JH; Liu LY; Zhang HZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4071-4078. PubMed ID: 29028094
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of MiR-1297 predicts poor prognosis and enhances gastric cancer cell growth by targeting CREB1.
Gao W; Cao Y; Guo P; Bao X; Zhu H; Zheng J; Yao C; Chen D; Yu S; Chen B; Zhou S; Pang D; Chen W
Biomed Pharmacother; 2018 Sep; 105():413-419. PubMed ID: 29870889
[TBL] [Abstract][Full Text] [Related]
19. MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA.
Du M; Zhang Y; Mao Y; Mou J; Zhao J; Xue Q; Wang D; Huang J; Gao S; Gao Y
Biochem Biophys Res Commun; 2017 Jan; 482(4):582-589. PubMed ID: 27856248
[TBL] [Abstract][Full Text] [Related]
20. The putative tumor suppressor microRNA-497 modulates gastric cancer cell proliferation and invasion by repressing eIF4E.
Li W; Jin X; Deng X; Zhang G; Zhang B; Ma L
Biochem Biophys Res Commun; 2014 Jun; 449(2):235-40. PubMed ID: 24845562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
